Pharma operations carry regulatory and traceability requirements generic ERPs handle awkwardly: batch and lot tracking, expiry management, narcotics compliance, GMP audit trails, and per-state licensing. Custom pharma ERP is built around these requirements as first-class data — not as add-on modules. Typical Indian projects: ₹15L–₹35L, 4–6 months, with audit-ready trails and AI-driven anomaly detection where useful.
Why pharma operations need ERP that fits
Pharma manufacturing and distribution are regulated end-to-end. The ERP is not a system of record sitting next to the operation — it is the system of record that auditors, drug controllers, and quality teams rely on. Generic ERPs handle this badly because they treat regulated workflows as add-on modules instead of first-class entities.
Three structural patterns make pharma different:
- Batch is the unit of operation. Not SKU, not lot — batch. Every receipt, every transfer, every dispatch needs to know which batch, which expiry, which manufacture date. ERPs that treat batches as a metadata tag instead of a primary entity fail at audit.
- Audit trail is statutory. Every change to every record needs to be recorded with timestamp and user. Tampering protections are not optional. Generic ERPs often have audit trail as an afterthought.
- Compliance is fragmented by state and category. Drug licenses, narcotics handling, schedule-specific rules, per-state stocking norms. The system needs to model these without forcing the operations team into spreadsheets for the parts the ERP cannot handle.
“In pharma, the ERP is the audit. If the system cannot show, in two clicks, where every gram of a batch went, the operation has a compliance gap regardless of how well it actually runs.”
Operational scope of a custom pharma ERP
| Area | What the system handles |
|---|---|
| Master data | Products with composition, schedule, regulatory tags, license requirements |
| Procurement | PO with vendor license validation, GRN with batch and expiry capture, lot-level QC |
| Manufacturing (where applicable) | Batch manufacturing record, in-process QC, yield tracking, deviations |
| Inventory | Batch and expiry tracking, FEFO picking, near-expiry alerts, controlled-substance vaults |
| Sales & dispatch | License validation per buyer, batch allocation, dispatch with traceability |
| Returns & recall | Batch-level returns, recall workflows, traceability forward and backward |
| Quality & deviations | Deviation logging, CAPA workflow, change control |
| Compliance | License renewal tracking, schedule-specific rules, audit-ready reports |
| Statutory reporting | GST, drug controller filings, state-specific reports |
What custom pharma ERP delivers that off-the-shelf cannot
| Capability | Generic ERP | Pharma-flavored framework | Custom ERP |
|---|---|---|---|
| Batch as primary entity | Metadata tag | Better | First-class — every entity tied to batch |
| Audit trail depth | Limited | Adequate | Designed in from schema level |
| Per-state regulatory rules | Workarounds | Configurable | Native to the data model |
| GMP audit-ready reports | Manual assembly | Templated | Built around the brand’s actual SOPs |
| AI for anomaly / yield analysis | Blocked | Limited | Direct — data layer is open |
| Customization tax over time | High | Medium | None |
The case for AI in pharma ERP — and why custom unblocks it
Pharma operations are full of high-value AI use cases: yield prediction by formula and lot, anomaly detection in QC results, expiry-driven dispatch optimization, demand forecasting by schedule and region. Off-the-shelf ERPs that gate the data layer make these features expensive or impossible. Custom ERPs put the data layer at the AI’s disposal directly.
For an example of unblocking AI on a custom ERP after replacing a vendor-gated SAAS, see our automotive scrap ERP case study. Same pattern applies to pharma.
What drives pharma ERP cost
- Regulatory scope — manufacturer vs distributor vs both, schedule coverage, narcotics
- Audit trail depth — basic vs full forensic-level with electronic signatures
- Multi-entity — separate manufacturing units, distribution arms, depots
- Statutory integration — drug controller portals, state-specific filings
- QC and deviation workflows — depth of CAPA, change control, deviation handling
- AI features — yield, QC anomaly, demand forecasting
For full cost ranges, see our custom ERP cost guide for India 2026.
When custom is the wrong answer for pharma
Honest counterpoint. Custom is not the right call when:
- Operations are small enough to run on Marg / Tally with bolt-on compliance tools
- You are part of a larger group standardized on SAP / Oracle and integration matters more than fit
- Regulatory environment is so volatile that vendor-managed updates are worth the customization tax
For most Indian mid-market pharma operations, none of those conditions hold. Custom is the right answer.
Pharma operations stuck on a misfit ERP?
If batch tracking is a workaround, audit trails feel half-baked, or regulatory reports get rebuilt manually each month, the ERP is the bottleneck. 30-minute call. We’ll tell you what custom would replace, and what it would cost.